Ventricular tachycardia ablation: indications, patient management, state of the art

█ Review

DOI: 10.26430/CHUNGARICA.2023.53.3.205

Authors:
Komlósi Ferenc, Tóth Patrik, Vámosi Péter, Szakál Imre, Szegedi Nándor, Zima Endre, Salló Zoltán, Perge Péter, Osztheimer István, Nagy Klaudia Vivien*, Gellér László*
Semmelweis Egyetem, Városmajori Szív- és Érgyógyászati Klinika, Budapest
*megosztott utolsó szerzők

Levelezési cím:
Dr. Nagy Klaudia Vivien, 1122 Budapest, Városmajor utca 68.

Summary
Ventricular tachycardia (VT) is one of the most common causes of sudden cardiac death, its most prevalent etiology being ischemic heart disease. Cornerstones of therapy include implantable cardioverter defibrillator (ICD), antiarrhythmic drugs and catheter ablation. While ICDs only prevent sudden cardiac death, antiarrhythmics are often ineffective and have serious side effects. Therefore, the rapid evolution of catheter ablation established its important role in the therapy of VT. In our paper we present the current indications of catheter ablation in VT, discussing the supporting body of evidence. We summarize the most common cases where referral to specialized centers is recommended. Additionally, we present some of the European and Hungarian statistics regarding VT management. Furthermore, we summarize the newest scientific discoveries in the field, focusing on two questions of intensive debate: whether catheter ablation can improve survival in VT and the incertainties around the optimal timing of catheter ablation.

ISSUE: CARDIOLOGIA HUNGARICA | 2023 | VOLUME 53, ISSUE 3

click here to read the full article		click here to read the pdf
Watch the video summary

---